BAQSIMI is authorized by the European health authorities for the treatment of severe Hypoglycaemia. Approval for price/reimbursement by the National Health System is pending in Spain

Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
08:00 - 08:45
Channel
Madrid
Lecture Time
08:45 - 08:45